Cardiac Toxicity Completed Phase 1 Trials for Dexrazoxane (DB00380)

IndicationStatusPhase
DBCOND0028520 (Cardiac Toxicity)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00039481Oblimersen Plus Combination Chemotherapy and Dexrazoxane in Treating Children and Adolescents With Relapsed or Refractory Solid TumorsTreatment